PHIBRO ANIMAL HEALTH CORP 8-K

What Happened
Phibro Animal Health Corporation (PAHC) announced on April 28, 2026 that it entered into Amendment No. 1 to its Credit Agreement with Coöperatieve Rabobank U.A., New York Branch acting as administrative agent, collateral agent and L/C issuer. The amendment raises the company’s revolving credit commitment from $310,000,000 to $435,000,000. The Original Credit Agreement was dated July 3, 2024; the amendment is filed as Exhibit 10.1 to the company’s Form 8-K.

Key Details

• Amendment No. 1 executed April 28, 2026 with Coöperatieve Rabobank U.A., New York Branch as administrative agent.
• Revolving credit commitment increased by $125,000,000 (from $310,000,000 to $435,000,000).
• The filing identifies the amendment as a material definitive agreement (Item 1.01) and a creation of a direct financial obligation (Item 2.03).
• A copy of Amendment No. 1 is included as Exhibit 10.1 to the 8-K.

Why It Matters
This amendment expands Phibro’s available borrowing capacity and liquidity, giving the company more flexibility to fund operations, capital needs, or strategic activities. For investors, a larger committed credit facility can reduce short-term funding risk and support cash flow management; the filing confirms the change is a material contractual obligation and provides the formal amendment for review.